The rights will enable Rona to significantly expand and accelerate Rona's siRNA portfolio in both liver and non-liver applications
SiRNA | 25/07/2022 | By Sudeep Soparkar | 724
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy